MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Charles River Laboratories Company Profile (NYSE:CRL)

Consensus Ratings for Charles River Laboratories (NYSE:CRL) (?)
Ratings Breakdown: 2 Sell Rating(s), 5 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.31)
Consensus Price Target: $81.09 (0.61% upside)

Analysts' Ratings History for Charles River Laboratories (NYSE:CRL)
Show:
DateFirmActionRatingPrice TargetActions
6/20/2016Credit SuisseInitiated CoverageNeutral$84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2016KeyBancReiterated RatingHold$77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2016BarclaysBoost Price TargetUnderweight$60.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016GabelliInitiated CoverageBuy$96.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Jefferies GroupReiterated RatingBuy$96.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Bank of AmericaReiterated RatingBuy$90.00 -> $87.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Goldman SachsBoost Price TargetSell$71.00 -> $74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Deutsche BankReiterated RatingHold$85.00 -> $82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2016Robert W. BairdBoost Price TargetOutperform$86.00 -> $92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Wells FargoUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Citigroup Inc.Reiterated RatingHold$75.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015Morgan StanleyReiterated RatingEqual Weight$65.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Edward JonesUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015SunTrustUpgradeNeutral -> Buy$88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Cantor FitzgeraldReiterated RatingBuy$78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Charles River Laboratories (NYSE:CRL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
5/4/2016Q116$0.90$0.98$354.92 million$354.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2016Q415$0.94$1.00$349.20 million$353.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315$0.94$1.03$340.09 million$349.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$0.97$0.96$338.30 million$339.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q115$0.82$0.79$324.00 million$320.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414$0.72$0.81$318.73 million$329.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q314$0.80$0.86$326.70 million$327.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214$0.82$0.97$327.96 million$341.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q114$0.74$0.82$302.08 million$299.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2014Q413$0.68$0.73$289.56 million$289.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013Q313$0.70$0.79$290.28 million$292.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.71$0.73$293.77 million$294.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q1 2013$0.71$0.69$294.53 million$291.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2013Q4 2012$0.60$0.64$280.81 million$280.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2012$0.62$0.65ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$0.66$0.75ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012$0.65$0.70ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2012$0.56$0.69ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.58$0.57ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011$0.60$0.70ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$0.55$0.61ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/8/2011$0.50$0.60ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Charles River Laboratories (NYSE:CRL)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20169$0.84$0.95$0.91
Q2 20167$1.00$1.13$1.09
Q3 20166$1.10$1.17$1.14
Q4 20166$1.06$1.32$1.17
Q1 20171$1.18$1.18$1.18
Q2 20172$1.21$1.23$1.22
Q3 20171$1.30$1.30$1.30
Q4 20171$1.31$1.31$1.31
(Data provided by Zacks Investment Research)
Dividend History for Charles River Laboratories (NYSE:CRL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Charles River Laboratories (NYSE:CRL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/24/2016John J CrowleyCAOSell1,913$85.00$162,605.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Richard F WallmanDirectorSell1,970$82.32$162,170.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Richard F WallmanDirectorSell11,990$84.00$1,007,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016George MassaroDirectorSell985$82.17$80,937.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Richard F WallmanDirectorSell2,720$81.00$220,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Davide MolhoVPSell30,667$80.00$2,453,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2016Nancy GillettVPSell7,015$75.00$526,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Nancy GillettVPSell3,646$73.50$267,981.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016David P JohstVPSell34,075$73.02$2,488,156.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016James C FosterCEOSell3,873$70.40$272,659.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016George M Milne JrDirectorSell10,440$73.02$762,328.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2016James C FosterCEOSell9,831$73.12$718,842.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016C Richard ReeseDirectorSell4,228$71.48$302,217.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016Nancy GillettVPSell6,750$71.90$485,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Stephen D ChubbDirectorSell2,000$74.76$149,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2015George MassaroDirectorSell7,740$80.00$619,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2015Thomas F. AckermaninsiderSell10,000$80.00$800,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2015Thomas F. AckermaninsiderSell10,000$75.00$750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015Thomas F. AckermaninsiderSell21,612$70.01$1,513,056.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Stephen D ChubbDirectorSell2,000$66.57$133,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Thomas F AckermanInsiderSell5,000$75.53$377,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Thomas F AckermanCFOSell3,900$70.51$274,989.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015George MassaroDirectorSell1,360$70.21$95,485.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Stephen D ChubbDirectorSell2,000$75.52$151,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Deborah Turner KochevarDirectorSell2,600$76.59$199,134.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015James C FosterCEOSell2,036$76.93$156,629.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Nancy GillettVPSell4,379$76.72$335,956.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2015Nancy GillettVPSell2,772$76.95$213,305.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2015James C FosterCEOSell4,621$75.96$351,011.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2015Nancy GillettVPSell5,015$76.12$381,741.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015James C FosterCEOSell4,800$75.70$363,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Jorg GellerVPSell12,061$76.17$918,686.37View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2015James C FosterCEOSell8,423$76.56$644,864.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2015Jorg GellerVPSell7,041$76.59$539,270.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015George M Milne JrDirectorSell6,000$75.87$455,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2015James C FosterCEOSell9,671$75.00$725,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Stephen D ChubbDirectorSell5,011$73.97$370,663.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Jorg GellerVPSell14,430$73.54$1,061,182.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Thomas F AckermanCFOSell4,400$73.50$323,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Davide MolhoVPSell19,075$74.00$1,411,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015Jorg GellerVPSell8,458$73.68$623,185.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015Thomas F AckermanCFOSell10,000$70.00$700,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2015David P JohstVPSell4,737$67.00$317,379.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2015David P JohstVPSell26,100$65.00$1,696,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Stephen D ChubbDirectorSell2,000$64.44$128,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014David P JohstVPSell6,982$65.34$456,203.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014Thomas F AckermanCFOSell10,000$63.70$637,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014Jorg GellerVPSell5,610$63.57$356,627.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2014C Richard ReeseDirectorSell5,849$63.39$370,768.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014John J CrowleyCAOSell1,000$64.00$64,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Davide MolhoVPSell16,402$64.54$1,058,585.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014George MassaroDirectorSell16,710$65.00$1,086,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Thomas F AckermanCFOSell36,100$65.00$2,346,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2014Nancy GillettVPSell1,069$65.00$69,485.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014David P JohstVPSell74,780$64.00$4,785,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014James C FosterCEOSell136,647$62.00$8,472,114.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/29/2014Thomas F AckermanCFOSell5,000$60.00$300,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014Davide MolhoVPSell4,900$61.34$300,566.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Stephen D ChubbDirectorSell2,000$59.18$118,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014George MassaroDirectorSell10,440$60.00$626,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014Thomas F AckermanCFOSell23,156$59.25$1,371,993.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Richard F WallmanDirectorSell3,240$58.20$188,568.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Stephen D ChubbDirectorSell2,000$52.93$105,860.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2014Deborah Turner KochevarDirectorSell3,100$53.30$165,230.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014George MassaroDirectorSell1,620$52.70$85,374.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2014Thomas AckermanCFOSell5,430$50.76$275,626.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014Nancy GillettVPSell10,110$58.36$590,019.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014Nancy GillettVPSell13,650$58.98$805,077.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014Stephen ChubbDirectorSell2,000$58.70$117,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2014Jorg GellerVPSell7,486$59.41$444,743.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014Nancy GillettVPSell4,000$60.00$240,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2014Jorg GellerVPSell3,188$58.49$186,466.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Nancy GillettVPSell4,000$58.96$235,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2014Stephen ChubbDirectorSell5,198$58.35$303,303.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Thomas AckermanCFOSell14,000$58.05$812,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2014David JohstVPSell19,750$58.00$1,145,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014George MassaroDirectorSell5,750$54.00$310,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/20/2013Thomas AckermanCFOSell5,000$52.72$263,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2013Jorg GellerVPSell7,200$51.93$373,896.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2013Stephen ChubbDirectorSell2,000$51.92$103,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013George MassaroDirectorSell5,958$47.38$282,290.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013James C FosterCEOSell174,479$47.00$8,200,513.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Thomas F AckermanCFOSell6,100$46.13$281,393.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Stephen ChubbDirectorSell2,000$46.49$92,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2013James FosterCEOSell40,983$47.00$1,926,201.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2013Davide MolhoVPSell6,500$47.93$311,545.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2013Stephen ChubbDirectorSell4,000$47.46$189,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Jorg GellerVPSell3,025$46.38$140,299.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Richard WallmanDirectorSell1,500$45.95$68,925.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Davide MolhoVPSell4,100$45.89$188,149.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Deborah Turner KochevarDirectorSell4,447$46.02$204,650.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Thomas AckermanCFOSell26,250$46.03$1,208,287.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Thomas F AckermanCFOSell4,000$42.40$169,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013James C FosterCEOSell113,810$45.00$5,121,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013George MassaroDirectorSell2,020$44.09$89,061.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2013David P JohstVPSell17,038$45.00$766,710.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Charles River Laboratories (NYSE:CRL)
DateHeadline
06/28/16 03:23 PMCovering the Bases on Charles River Laboratories International, Inc. (NYSE:CRL): Where is the Stock Going? - Press Telegraph
06/28/16 03:23 PMShares in Decline this Year Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
06/28/16 03:23 PMMost Active Mix Cap Movers- Charles River Laboratories International (NYSE:CRL), Monsanto (NYSE:MON), Relypsa ... - Seneca Globe
06/28/16 03:23 PMCharles River Laboratories (CRL) Announces Acquisition of Blue Stream Laboratories - StreetInsider.com
06/28/16 08:17 AMCharles River Laboratories (CRL) Announces Acquisition of Blue Stream Laboratories
06/27/16 07:57 AMStock Performance Focus on: Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
06/27/16 07:57 AMShare Update and Earnings Review for Charles River Laboratories International, Inc. (NYSE:CRL) - Press Telegraph
06/23/16 02:16 PMNew Broker Ratings For Charles River Laboratories International, Inc. (NYSE:CRL) - FTSE News
06/22/16 08:39 PMCharles River Laboratories (NYSE:CRL) target price upped to $84, reported today by Credit Suisse
06/22/16 03:34 PMCharles River Laboratories International, Inc. (NYSE:CRL) Annual Accrued Expenses At $162.326 Millions - Stocks Daily
06/21/16 03:16 PMCharles River Labs (CRL) Stock Falls, Credit Suisse Initiates Coverage - TheStreet.com
06/21/16 01:22 PMCharles River Labs (CRL) Stock Falls, Credit Suisse Initiates Coverage -
06/21/16 10:23 AMCharles River Laboratories International, Inc. – Value Analysis (NYSE:CRL) : June 21, 2016 -
06/21/16 04:42 AMCoverage initiated on Charles River by Credit Suisse -
06/20/16 07:35 AMCharles River Laboratories International, Inc. breached its 50 day moving average in a Bearish Manner : CRL-US : June 20, 2016 -
06/16/16 07:46 AMTrend Of Rating Given To Charles River Laboratories International, Inc. (NYSE:CRL) - Investor Newswire
06/15/16 03:21 PMCHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets -
06/14/16 03:17 PMCharles River Lab. To Present At William Blair Conference; Webcast At 2:30 PM
06/09/16 03:26 PMRatings Watch: Charles River Laboratories International, Inc. (NYSE:CRL) - Investor Newswire
06/09/16 03:26 PMCharles River Laboratories International, Inc. (NYSE:CRL) Fundamental Star Rating Report - CML News
06/09/16 08:13 AMNow Available: Charles River Laboratories International, Inc. (CRL) - Financial and Strategic SWOT Analysis Review
06/06/16 08:48 PMCHARLES RIVER LABORATORIES INTERNATIONAL INC. (NYSE:CRL) Financial Condition Compared to S&P 500 - CML News
06/06/16 03:13 PMCharles River Laboratories to Present at Jefferies and William Blair Conferences - Business Wire (press release)
06/06/16 03:13 PMModerna Therapeutics and Charles River Laboratories Announce Strategic Collaboration to Scale Moderna's ... - Business Wire (press release)
06/06/16 07:38 AMCharles River Laboratories to Present at Jefferies and William Blair Conferences - [at noodls] - WILMINGTON, Mass.--(BUSINESS WIRE)--Jun. 6, 2016-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2016 Global Healthcare Conference in ...
06/05/16 11:09 AMCharles River Laboratories International, Inc. (NYSE:CRL) Broker Price Targets For The Coming Week - Share Trading News
06/03/16 03:31 PMBuy, Sell Or Hold Rating For Charles River Laboratories International, Inc. (NYSE:CRL)? - Share Trading News
06/02/16 09:27 PMCharles River Laboratories International, Inc. (NYSE:CRL) Quarterly EPS Estimate At $1.15 - Investor Newswire - Charles River Laboratories International, Inc. (NYSE:CRL) Quarterly EPS Estimate At $1.15Investor NewswireFirst Call stated that Charles River Laboratories International, Inc. (NYSE:CRL) can touch $85.57 in coming one year. For the next quarter, the per-share earnings target is $1.15 and for ongoing fiscal at $4.40. EPS target for next year is $5.01 versus ...and more »
05/31/16 09:06 PMShares Touching a Recent High: Charles River Laboratories International, Inc. (NYSE:CRL) - HNN - Shares Touching a Recent High: Charles River Laboratories International, Inc. (NYSE:CRL)HNNCharles River Laboratories International, Inc. (NYSE:CRL)'s stock has seen a steady move upward, reaching $85.64 on a recent bid, generating strong interest amongst investors and analysts alike. Shareholders are noting a Return on Investment (ROI) of ...and more »
05/31/16 03:26 PMShare Rating Focus on Charles River Laboratories International, Inc. (NYSE:CRL) - HNN - Share Rating Focus on Charles River Laboratories International, Inc. (NYSE:CRL)HNNPresently, Wall Street analysts have given a consensus stock rating of 2 on shares of Charles River Laboratories International, Inc. (NYSE:CRL). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research.and more »
05/31/16 03:26 PMCharles River Laboratories International, Inc. (NYSE:CRL) Set To Release Quarterly Earnings - Investor Newswire - Charles River Laboratories International, Inc. (NYSE:CRL) Set To Release Quarterly EarningsInvestor NewswireAccording to a group of market experts surveyed by Zacks Research, Charles River Laboratories International, Inc. (NYSE:CRL) is projected to report earnings of $1.23 for its recent quarter. The company plans to release its quarterly report on or around ...and more »
05/30/16 07:32 PMPerformance at a Glance on Charles River Laboratories International, Inc. (NYSE:CRL) - HNN - Performance at a Glance on Charles River Laboratories International, Inc. (NYSE:CRL)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how Charles River Laboratories International, Inc. (NYSE:CRL)'s stock has performed at various points in ...and more »
05/30/16 07:32 PMHold Calls Count For Charles River Laboratories International, Inc. (NYSE:CRL) At 5 - RealistInvestor.com - Hold Calls Count For Charles River Laboratories International, Inc. (NYSE:CRL) At 5RealistInvestor.comBuy calls count on Charles River Laboratories International, Inc. (NYSE:CRL)'s stock stands at 0 while Sell recommendations is 0. Hold recommendation is 5. Charles River Laboratories International, Inc. (NYSE:CRL) has a total of 8 Strong Buy ...and more »
05/30/16 07:32 PMCharles River Laboratories (NYSE:CRL) Receives Consensus Recommendation of “Hold” from Analysts - Let Me Know About This - Charles River Laboratories (NYSE:CRL) Receives Consensus Recommendation of “Hold” from AnalystsLet Me Know About ThisCharles River Laboratories logo Shares of Charles River Laboratories (NYSE:CRL) have received a consensus recommendation of “Hold” from the fourteen brokerages that are currently covering the stock. Two analysts have rated the stock with a sell ...How Analysts Feel About Charles River Laboratories Intl. Inc (NYSE:CRL)?Franklin IndependentCharles River Laboratories International, Inc. (NYSE:CRL) Cash From Financial Activities Stands At $4.548 MillionsVanguard TribuneA Winning Pick this Year: Charles River Laboratories International, Inc. (NYSE:CRL)The PostShare Trading News -Finance Dailyall 7 news articles »
05/16/16 08:26 AMCHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K/A, Change in Directors or Principal Officers -
04/14/16 11:44 AMFirst Week of April 15th Options Trading For Charles River Laboratories International (CRL) - Investors in Charles River Laboratories International Inc. (Symbol: CRL) saw new options become available this week, for the April 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRL options chain for the new ...
04/09/16 01:49 PMIs Charles River Laboratories International, Inc. (NYSE:CRL) a Consensus Buy? - Clinton Financial - Is Charles River Laboratories International, Inc. (NYSE:CRL) a Consensus Buy?Clinton FinancialEquity research firms covering public U.S companies have a workforce of analysts dedicating their time covering the most popular stocks. Their reports are delivered to institutional investors in order to help make investment decisions. The information ...and more »
04/07/16 03:51 PMCharles River Laboratories Schedules First-Quarter 2016 Earnings Release and Conference Call - [at noodls] - WILMINGTON, Mass.--(BUSINESS WIRE)--Apr. 7, 2016-- Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2016 financial results on Wednesday, May 4 before the market opens. ...
04/05/16 08:18 AMCHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, -
04/04/16 08:17 AMCharles River Laboratories Completes the Acquisition of WIL Research - [at noodls] - WILMINGTON, Mass.--(BUSINESS WIRE)--Apr. 4, 2016-- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that it has completed the previously announced acquisition of WIL Research for ...
03/15/16 12:38 PMCRL Makes Notable Cross Below Critical Moving Average - In trading on Tuesday, shares of Charles River Laboratories International Inc. (Symbol: CRL) crossed below their 200 day moving average of $72.58, changing hands as low as $72.02 per share. Charles River Laboratories International Inc. shares are currently ...
03/14/16 07:24 AMCharles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : March 14, 2016 -
03/10/16 07:29 AMCHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers -
03/07/16 07:30 AMCharles River Laboratories to Present at Raymond James Conference - [Business Wire] - Charles River Laboratories International, Inc. announced today that it will present at the Raymond James 37th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 8th, at 10:25 a.m.
03/03/16 07:10 AMCharles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : March 3, 2016 -
02/29/16 04:00 AMEdited Transcript of CRL earnings conference call or presentation 7-Aug-14 1:00pm GMT -
02/28/16 01:31 PMEarnings Surprise in Focus: Charles River Laboratories International, Inc. (NYSE:CRL) - Investor Newswire - Earnings Surprise in Focus: Charles River Laboratories International, Inc. (NYSE:CRL)Investor NewswireFor the most recent quarter, Charles River Laboratories International, Inc. (NYSE:CRL) reported earnings per share of $1 for the fiscal period ending on 2015-12-31, an earnings surprise factor of 6.38%. The actual number was $0.06 away from the ...and more »
02/26/16 08:45 AMMichael J. Fox Foundation Partners with Charles River Laboratories on Parkinson's Research - Bioscience Technology - Bioscience TechnologyMichael J. Fox Foundation Partners with Charles River Laboratories on Parkinson's ResearchBioscience TechnologyExperts from Charles River Laboratories (CRL) spoke to Bioscience Technology and answered a few questions about the partnership and research goals. David Fischer, Ph.D., is Executive Director of Biology and Drug Metabolism and Pharmacokinetics ...
02/26/16 08:45 AMMichael J. Fox Foundation Partners with Charles River Laboratories on Parkinson’s Research - Experts from Charles River Laboratories (CRL) spoke to Bioscience Technology and answered a few questions about the partnership and research goals. David Fischer, Ph.D., is Executive Director of Biology and Drug Metabolism and Pharmacokinetics Discovery ...
02/22/16 01:56 PMAnalyst Coverage Updates - Charles River Laboratories International, Inc. (NYSE:CRL) - Risers & Fallers - Analyst Coverage Updates - Charles River Laboratories International, Inc. (NYSE:CRL)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Charles River Laboratories International, Inc. (NYSE:CRL). The latest broker reports which are currently outstanding on Monday 22nd of February state 6 analysts have a ...and more »
About Charles River Laboratories

Charles River Laboratories logoCharles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company is engaged in the business of providing the research models required in research and development of new drugs, devices and therapies. The Company operates through three segments: Research Models and Services (RMS), which consists of Research Models and Research Model Services; Discovery and Safety Assessment (DSA), which offers discovery and safety assessment services, both regulated and non-regulated, in which it includes both in vivo and in vitro studies, and Manufacturing Support (Manufacturing), which includes Microbial Solutions, Biologics Testing Solutions and Avian Vaccine Services. It has developed a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, which is able to support its clients from target identification through preclinical development.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NYSE
  • Symbol: CRL
  • CUSIP: 15986410
Key Metrics:
  • Previous Close: $80.60
  • 50 Day Moving Average: $83.80
  • 200 Day Moving Average: $78.36
  • P/E Ratio: 24.80
  • P/E Growth: 1.48
  • Market Cap: $3.80B
  • Current Quarter EPS Consensus Estimate: $4.39 EPS
Additional Links:
Charles River Laboratories (NYSE:CRL) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha